Plain Language Summary of a Phase 2 Study of Triamcinolone Acetonide Extended-Release for Pain Relief in People With Knee Osteoarthritis and Type 2 Diabetes
Therapeutic Advances in Musculoskeletal Disease
Published online on April 10, 2026
Abstract
Therapeutic Advances in Musculoskeletal Disease, Volume 18, January-December 2026.
SummaryWhat is this summary about?This plain language summary of publications outlines 2 publications that represent 2 separate analyses of a single study of triamcinolone acetonide extended-release (TA-ER). TA-ER is an injection into the knee joint ...
SummaryWhat is this summary about?This plain language summary of publications outlines 2 publications that represent 2 separate analyses of a single study of triamcinolone acetonide extended-release (TA-ER). TA-ER is an injection into the knee joint ...